Catalyst Wire Dossier Catalyst Wire Dossier

ASC47

· Ascletis Pharma (China) Co., Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASC47, covering 2025-05-11 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide [Phase 1]

See pricing